|
May 8
|
Photocure ASA: Results for the first quarter of 2025
|
|
Apr 29
|
Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making
|
|
Feb 17
|
Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025
|
|
Jul 15
|
Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization
|
|
Nov 29
|
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China
|
|
Nov 8
|
Photocure ASA: Results for the third quarter of 2023
|
|
Aug 9
|
Photocure ASA: Results for the second quarter and first half of 2023
|